17 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
19
Synthesis and biological evaluation of 3-substituted 5-benzylidene-1-methyl-2-thiohydantoins as potent NADPH oxidase (NOX) inhibitors.
Ewha Womans University
17
Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors.
Genkyotex
63
First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.
Genkyotex
12
Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB Inhibitor.
Sapienza University of Rome
17
Bridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitors.
University of Pittsburgh
23
COMPOUND ACTIVE AS INHIBITOR OF COLONY STIMULATION FACTOR-1 RECEPTOR (CSF-1R)
Norwegian University of Science and Technology
17
Heteroaryl compounds as inhibitors of TYK2, composition and application thereof
Accro Bioscience (Hk)
4
Inhibitors of protein tyrosine phosphatases
Indiana University Research and Technology
44
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Abbvie
16
Design and synthesis of novel 2-amino-5-hydroxyindole derivatives that inhibit human 5-lipoxygenase.
Friedrich Alexander University Erlangen
51
Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase.
Bristol Myers Squibb
30
Structure-activity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a class of 5-HT7 receptor agents. 2.
Universita Degli Studi Di Bari